Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
67 USD | 0.00% | -0.27% | +7.67% |
16/05 | Axonics Implant Approved in Australia to Treat Overactive Bladders | MT |
16/05 | Axonics, Inc. Receives Regulatory Approval for Recharge-Free SNM System in Australia | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.67% | 3.42B | |
+15.68% | 132B | |
-6.03% | 11.37B | |
-8.81% | 7.97B | |
+42.76% | 5.71B | |
-17.67% | 4.98B | |
-19.40% | 2.48B | |
-15.33% | 1.99B | |
-16.30% | 1.86B | |
-30.89% | 1.6B |
- Stock Market
- Equities
- AXNX Stock
- News Axonics, Inc.
- Axonics Implant Approved in Australia to Treat Overactive Bladders